Join the 'Cryopyrin-Associated Periodic Syndromes' group to help and get support from people like you.
Cryopyrin-Associated Periodic Syndromes News
Related terms: CAPS
Posted 8 Jan 2013 by Drugs.com
Sobi (STO: SOBI) today announced that the US Food and Drug Administration (FDA) has approved Kineret® (anakinra) for the treatment of children and adults with neonatal-onset multisystem inflammatory disease (NOMID). Kineret is the first and only FDA-approved therapy for NOMID, the most severe form of cryopyrin associated periodic syndromes (CAPS). This is the first approval allowing the use of ...